Abstract Background ‘Next-generation’ (NGS) sequencing has wide application in medical genetics, including the detection of somatic variation in cancer. The Ion Torrent-based (IONT) platform is among NGS technologies employed in clinical, research and diagnostic settings. However, identifying mutations from IONT deep sequencing with high confidence has remained a challenge. We compared various computational variant-calling methods to derive a variant identification pipeline that may improve the molecular diagnostic and research utility of IONT. Results Using IONT, we surveyed variants from the 409-gene Comprehensive Cancer Panel in whole-section tumors, intra-tumoral biopsies and matched normal samples obtained from frozen tissues and blood...
The Ion Torrent Personal Genome Machine (Ion PGM) is a semiconductor-based sequencing technology tha...
The Ion Torrent Personal Genome Machine (Ion PGM) is a semiconductor-based sequencing technology tha...
Monitoring of minimal residual disease (MRD) has become an important clinical aspect for early relap...
The detection of somatic genetic variants forms the cornerstone of precision oncology. Molecular dia...
Use of next-generation sequencing to detect somatic variants in DNA extracted from formalin-fixed, p...
textabstractBackground Targeted Next Generation Sequencing (NGS) offers a way to implement testing o...
BACKGROUND: Targeted Next Generation Sequencing (NGS) offers a way to implement testing of multiple ...
BACKGROUND: Targeted Next Generation Sequencing (NGS) offers a way to implement testing of multiple ...
Treatment for patients with advanced non-small cell lung cancer (NSCLC) is often determined by the p...
Treatment for patients with advanced non-small cell lung cancer (NSCLC) is often determined by the p...
Detection of somatic mutations in non-small cell lung cancers ( NSCLCs), especially adenocarcinomas,...
Next-generation sequencing (NGS) is becoming a common approach for clinical testing of oncology spec...
AbstractDetection of somatic mutations in non–small cell lung cancers (NSCLCs), especially adenocarc...
Next-generation sequencing (NGS) is becoming a common approach for clinical testing of oncology spec...
Detection of somatic mutations holds great potential in cancer treatment and has been a very active ...
The Ion Torrent Personal Genome Machine (Ion PGM) is a semiconductor-based sequencing technology tha...
The Ion Torrent Personal Genome Machine (Ion PGM) is a semiconductor-based sequencing technology tha...
Monitoring of minimal residual disease (MRD) has become an important clinical aspect for early relap...
The detection of somatic genetic variants forms the cornerstone of precision oncology. Molecular dia...
Use of next-generation sequencing to detect somatic variants in DNA extracted from formalin-fixed, p...
textabstractBackground Targeted Next Generation Sequencing (NGS) offers a way to implement testing o...
BACKGROUND: Targeted Next Generation Sequencing (NGS) offers a way to implement testing of multiple ...
BACKGROUND: Targeted Next Generation Sequencing (NGS) offers a way to implement testing of multiple ...
Treatment for patients with advanced non-small cell lung cancer (NSCLC) is often determined by the p...
Treatment for patients with advanced non-small cell lung cancer (NSCLC) is often determined by the p...
Detection of somatic mutations in non-small cell lung cancers ( NSCLCs), especially adenocarcinomas,...
Next-generation sequencing (NGS) is becoming a common approach for clinical testing of oncology spec...
AbstractDetection of somatic mutations in non–small cell lung cancers (NSCLCs), especially adenocarc...
Next-generation sequencing (NGS) is becoming a common approach for clinical testing of oncology spec...
Detection of somatic mutations holds great potential in cancer treatment and has been a very active ...
The Ion Torrent Personal Genome Machine (Ion PGM) is a semiconductor-based sequencing technology tha...
The Ion Torrent Personal Genome Machine (Ion PGM) is a semiconductor-based sequencing technology tha...
Monitoring of minimal residual disease (MRD) has become an important clinical aspect for early relap...